T2 Biosystems Shares Plummet 47% on 3Q Revenue Outlook
By Denny Jacob T2 Biosystems shares plummeted 47% to $9.19 on forecasts of lower revenue in the third-quarter. The stock is down 93% on the year so far....
John Sperzel Denny Jacob Development Authority Biomedical Advanced Research Executive John Sperzel Article Normal
Source: marketwatch.com